3D Global Biotech (ROCO:6808) Net Margin %: 25.09% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6808 3D Global Biotech Inc ROCO:6808
70 GF Score
Price NT$38.85
GF Value NT$185.91
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is 3D Global Biotech Net Margin %?

3D Global Biotech ROCO:6808 -3.00% 70 Net Margin % is 25.09% as of Dec. 2025. GuruFocus rates ROCO:6808 with a GF Score™ of 70/100 and a GF Value™ of NT$185.91 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 941 Biotechnology companies, 3D Global Biotech ranks better than 91.18% on this metric.

Net margin is calculated as Net Income divided by its Revenue. 3D Global Biotech's Net Income for the six months ended in Dec. 2025 was NT$26.1 Mil. 3D Global Biotech's Revenue for the six months ended in Dec. 2025 was NT$103.9 Mil. Therefore, 3D Global Biotech's net margin for the quarter that ended in Dec. 2025 was 25.09%.

The historical rank and industry rank for 3D Global Biotech's Net Margin % or its related term are showing as below:

ROCO:6808' s Net Margin % Range Over the Past 10 Years
Min: -539.1   Med: -335.4   Max: 34.51
Current: 32.18

ROCO:6808's Net Margin % is ranked better than
91.18% of 941 companies
in the Biotechnology industry
Industry Median: -88.29 vs ROCO:6808: 32.18

3D Global Biotech  (ROCO:6808) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

3D Global Biotech Net Margin % Related Terms

3D Global Biotech Net Margin % Historical Data

* Premium members only.

The historical data trend for 3D Global Biotech's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3D Global Biotech Net Margin % Chart

3D Global Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only -539.10 -491.72 -280.87 34.51 32.18

3D Global Biotech Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -241.14 -3.92 42.07 39.34 25.09

ROCO:6808 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, 3D Global Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3D Global Biotech Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3D Global Biotech's Net Margin % distribution charts can be found below:

* The bar in red indicates where 3D Global Biotech's Net Margin % falls into.


ROCO:6808
70GF Score
3D Global Biotech Inc ROCO:6808
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

3D Global Biotech Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

3D Global Biotech's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=66.526/206.735
=32.18 %

3D Global Biotech's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=26.065/103.891
=25.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 25.09% mean?
3D Global Biotech (ROCO:6808) has a Net Margin % of 25.09% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on 3D Global Biotech and its competitors. According to the industry distribution chart, 3D Global Biotech ranks #83 out of 941 companies in the Biotechnology industry, placing it in the top 8.8%.
Is 3D Global Biotech's Net Margin % too high?
3D Global Biotech's current Net Margin % is 25.09%. Based on the distribution chart, 3D Global Biotech ranks #83 out of 941 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, 3D Global Biotech has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does 3D Global Biotech's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, 3D Global Biotech ranks #83 out of 941 companies for Net Margin %. This places 3D Global Biotech in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on 3D Global Biotech and its competitors. 3D Global Biotech's current Net Margin % is 25.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3D Global Biotech stock overvalued right now?
Based on GuruFocus' analysis, 3D Global Biotech (ROCO:6808) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$185.91, compared to a current price of NT$38.85 — trading 79.1% below its estimated fair value. The current Net Margin % is 25.09%. 3D Global Biotech's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For 3D Global Biotech (ROCO:6808), the current Net Margin % is 25.09% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 3D Global Biotech (ROCO:6808) Overvalued in 2026?

Based on GuruFocus' analysis, 3D Global Biotech stock appears to be undervalued. The current stock price of NT$38.85 is trading 79.1% below its estimated GF Value™ of NT$185.91. GuruFocus considers 3D Global Biotech to be Significantly Undervalued.

Key valuation signals for ROCO:6808:

  • Net Margin %: 25.09%
  • GF Value™: NT$185.91 vs. price of NT$38.85 (79.1% below fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6808 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

3D Global Biotech Business Description

Address No.99, Section 1, Xintai 5th Road, 21st Floor -3, Xizhi District, New Taipei, TWN, 221
3D Global Biotech Inc is engaged in the research and development of high-end medical equipment and biological 3D printing technology and the sale of medical Materials and other related products.
70GF Score

Get the complete analysis for ROCO:6808

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.85
Price
NT$185.91
GF Value